60 Degrees Pharmaceuticals, Inc. (SXTP)
0.8701
-0.01
(-0.66%)
USD |
NASDAQ |
Oct 23, 16:00
0.8758
+0.01
(+0.66%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Net Income (Quarterly) : -2.263M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.263M |
| March 31, 2026 | -2.084M |
| December 31, 2025 | -1.440M |
| September 30, 2025 | -2.316M |
| June 30, 2025 | -1.718M |
| March 31, 2025 | -1.887M |
| December 31, 2024 | -2.053M |
| September 30, 2024 | -2.156M |
| June 30, 2024 | -4.171M |
| Date | Value |
|---|---|
| March 31, 2024 | 0.4241M |
| December 31, 2023 | -1.992M |
| September 30, 2023 | 4.174M |
| June 30, 2023 | -3.344M |
| March 31, 2023 | -2.598M |
| September 30, 2022 | -1.451M |
| March 31, 2022 | -0.9074M |
| December 31, 2021 | -1.365M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Harrow, Inc. | -17.27M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.2079M |
| Total Expenses (Quarterly) | 2.470M |
| EPS Diluted (Quarterly) | -0.903 |
| Enterprise Value | 10.92M |
| Gross Profit Margin (Quarterly) | 27.32% |
| Profit Margin (Quarterly) | -1.09K% |
| Earnings Yield | -711.4% |
| Normalized Earnings Yield | -738.39 |